These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28748994)

  • 1. [Intravenous thrombolysis for acute ischemic stroke. A four years’ experience in a Chilean public hospital].
    Soto V Á; Morales I G; Grandjean B M; Pollak W D; Del Castillo C C; García F P; Von Johnn A A; Riquelme G A
    Rev Med Chil; 2017 Apr; 145(4):468-475. PubMed ID: 28748994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous thrombolysis for ischemic stroke: Experience in 54 patients].
    Guevara O C; Bulatova K; Aravena F; Caba S; Monsalve J; Lara H; Nieto E; Navarrete I; Morales M
    Rev Med Chil; 2016 Apr; 144(4):434-41. PubMed ID: 27401375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
    Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
    BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis.
    Tsivgoulis G; Zand R; Katsanos AH; Goyal N; Uchino K; Chang J; Dardiotis E; Putaala J; Alexandrov AW; Malkoff MD; Alexandrov AV
    Stroke; 2015 May; 46(5):1281-7. PubMed ID: 25791717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.
    Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Karapanayiotides T; Giannopoulos S; Mikulik R
    Eur J Neurol; 2017 Dec; 24(12):1493-1498. PubMed ID: 28888075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY; Lin HJ; Sung SF; Yang YH; Lai EC; Hsieh HC; Chen CH
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.
    Tsivgoulis G; Alexandrov AV; Chang J; Sharma VK; Hoover SL; Lao AY; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Frey JL
    Stroke; 2011 Jun; 42(6):1771-4. PubMed ID: 21493900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolysis in stroke mimics: Experience in 10 cases].
    Brunser AM; Hoppe A; Muñoz P; Lavados PM; Illanes S; Díaz V; Olavarría VV
    Rev Med Chil; 2016 Oct; 144(10):1266-1269. PubMed ID: 28074981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke.
    Choi JC; Jang MU; Kang K; Park JM; Ko Y; Lee SJ; Cha JK; Kim DH; Park SS; Park TH; Lee KB; Lee J; Kim JT; Cho KH; Yu KH; Oh MS; Lee BC; Cho YJ; Kim DE; Lee JS; Lee J; Gorelick PB; Bae HJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001306. PubMed ID: 25628404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.